Giuseppe Chiarelli, Alex Stephens, Marco Finati, Giuseppe Ottone Cirulli, Edoardo Beatrici, Dejan K Filipas, Sohrab Arora, Shane Tinsley, Mahendra Bhandari, Giuseppe Carrieri, Quoc-Dien Trinh, Alberto Briganti, Francesco Montorsi, Giovanni Lughezzani, Nicolò Buffi, Craig Rogers, Firas Abdollah
PURPOSE: We aimed to assess the appropriateness of ChatGPT in providing answers related to prostate cancer (PCa) screening, comparing GPT-3.5 and GPT-4. METHODS: A committee of five reviewers designed 30 questions related to PCa screening, categorized into three difficulty levels. The questions were formulated identically for both GPTs three times, varying the prompts. Each reviewer assigned a score for accuracy, clarity, and conciseness. The readability was assessed by the Flesch Kincaid Grade (FKG) and Flesch Reading Ease (FRE)...
April 2, 2024: International Urology and Nephrology